Cardiol Therapeutics: Advancing Cardio Anti‑Inflammatory Drugs Despite Ongoing R&D Losses
Cardiol Therapeutics, a Toronto‑listed life science firm, advances anti‑inflammatory small‑molecule therapies for cardiovascular disease while strengthening its cash base and managing R&D spending.
2 minutes to read


